Picture of Torrent Pharmaceuticals logo

TORNTPHARM — Torrent Pharmaceuticals News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

India's Torrent Pharma jumps on quarterly profit rise

** Shares of India's Torrent Pharma TORP.NS jumps 5.4% to 4300 rupees; set for biggest single-day pct gain since July 2025

** Drugmaker posted 26% y/y rise in Q3 net profit to 6.35 billion rupees ($70.04 million), declared a dividend of 29 rupees per share

** Jefferies ("Buy", PT:4690 rupees) says co's December-quarter profit rose broadly in line with estimates, aided by strong India and Brazil performance

** Ambit ("Buy", PT:4150 rupees) says profit was supported by strong branded-market growth, and US launch-led momentum, with margins steady on operating leverage

** Brokerage Antique ("Buy", PT:4610 rupees) attributes the in-line profit to India's outperformance, US launch momentum, and Brazil's strength, driving revenue growth and stable margins

** TORP rated "buy" on average by 27 analysts, PT at 4141 rupees -- data compiled by LSEG

** TORP gained 14.6% in 2025, and the stock jumped ~6% so far in 2026

($1 = 90.6590 Indian rupees)

(Reporting by Surbhi Misra in Bengaluru)

((Surbhi.Misra@thomsonreuters.com |  X: https://twitter.com/SurbhiMisra_  |;))

Recent news on Torrent Pharmaceuticals

See all news